HIGHLIGHTS
- who: Weixiong Jian from the New York University, United States have published the research work: Efficacy and safety of dorzagliatin for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis, in the Journal: (JOURNAL)
- how: The authors chose to evaluate the quality of the evidence by using GRADEpro3.6 software and the evaluation method was based on the GRADE evidence evaluation guidelines. All work was conducted independently by two investigators and any disagreement was resolved by a third investigator.
SUMMARY
And the evidence-based evidence of dorzagliatin for T2DM . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.